Section to complete information about primary and secondary outcomes including. It includes the metric or method of measurement used and, the time point for every outcome.
Primary outcome(s):
“Serum levels of pegylated IFN by EIA” and “Antiviral activity of the pegylated IFN” variables, measurement time: 336 hours.
Key secondary outcomes:
1. ''Beta-2 micro globulin'', “2',5'-oligoadenylate synthetase'', and ''neopterin'' variables, measurement time: 336 hours. 2. “Safety of the treatment” variable, measurement time: 336 hours.